StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-1.00%)

Close on Nov 18, 2026Market cap $452.45KP/E –Yield –

Arcadia Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Arcadia Biosciences's price to book ratio was 0.8× on Apr 30, 2025, against 0.2× a year earlier. Over the last 5 years it ranged from 0.2× to 3.2×, with a median of 0.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20250.8×−0.0
2024Dec 31, 20240.8×+0.6
2023Dec 29, 20230.2×−0.0
2022Dec 30, 20220.3×−0.3
2021Dec 31, 20210.6×−1.9
2020Dec 31, 20202.4×−1.1
2019Dec 31, 20193.5×+2.3
2018Dec 31, 20181.2×+0.1
2017Dec 29, 20171.1×−0.4
2016Dec 30, 20161.5×−1.6
2015Dec 31, 20153.0×–

More Arcadia Biosciences figures

See a number that looks wrong?